Synthetic GLP-1 receptor agonists are long acting with a 13 hour half-life and have been shown to improve glycemic control and aid in weight loss
- Follow CMS and payer guidance: Use the latest guidance and requirements to avoid errors or claim denials - Ensure accuracy: Double-check claim forms to verify that the patient information, diagnosis codes, and service details are correct and complete ## **Other relevant codes** - J1745 Infliximab, 10 mg (reference product) - J3490 Unclassified drugs Frequently asked questions
Its worth noting that Tirzepatide (via Mounjaro) is available by prescription in Canada with a type 2 diabetes diagnosis, and Semaglutide (Wegovy) is available for weight management
Fatigue or Dizziness: Transient lethargy has been noted early on, possibly from metabolic shifts or inflammation reduction
May need temporary hold perioperatively though some surgeons supportive continuing for healing support
- BPC-157 + GLP-1 agonists: BPC-157 may provide GI protection against GLP-1 side effects, but monitor closely as both affect gastric motility
